Advertisement

Therapie mittels Schmerzpumpen und Ports

  • Hans Georg Kress

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Aldrete JA (1995) Epidural fibrosis after permanent catheter insertion and infusion. J Pain Sympt Manage 10: 624–631CrossRefGoogle Scholar
  2. 2.
    Bedder MD, Burchiel K, Larson A (1991) Cost analysis of two implantable narcotic delivery systems. J Pain Sympt Manage 6: 368–373CrossRefGoogle Scholar
  3. 3.
    Coffey RJ, Burchiel K (2002) Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations on 41 patients. Neurosurgery 50: 78–86PubMedCrossRefGoogle Scholar
  4. 4.
    Cools HJ, Berkhout AM, De Bock GH (1996) Subcutaneous morphine infusion by syringe driver for terminally ill patients. Age Ageing 25: 206–208PubMedGoogle Scholar
  5. 5.
    Dahm P, Nitescu P, Appelgren L, Curelaru I (1998) Efficacy and technical complications of long-term continuous intraspinal infusions of opioid and/or bupivacaine in refractory nonmalignant pain: a comparison between the epidural and the intrathecal approach with externalized or implanted catheters and infusion pumps. Clin J Pain 14: 4–16PubMedCrossRefGoogle Scholar
  6. 6.
    Devulder J, Ghys L, Dhondt W, Rolly G (1994) Spinal analgesia in terminal care: risk versus benefit. J Pain Sympt Manage 9: 75–81CrossRefGoogle Scholar
  7. 7.
    Drexel H, Dzien A, Spiegel RW, Lang AH, Breier C et al (1989) Treatment of severe cancer pain by low-dose continuous subcutaneous morphine. Pain 36: 169–176PubMedCrossRefGoogle Scholar
  8. 8.
    Eisenach JC, Rauck RL, Buzzanell C, Lysak SZ (1989) Epidural clonidine analgesia for intractable cancer pain: Phase I. Anesthesiology 71: 647–652PubMedGoogle Scholar
  9. 9.
    Eisenach JC, Du Pen S, Dubois M, Miguel R, Allin D (1995) Epidural clonidine analgesia for intractable cancer pain. Pain 61: 391–399PubMedCrossRefGoogle Scholar
  10. 10.
    Hassenbusch S, Burchiel K, Coffey RJ, Cousins MJ, Deer T, Hahn MB, Pen SD, Follett KA, Krames E, Rogers JN, Sagher O, Staats PS, Wallace M, Willis KD (2002) Management of intrathecal catheter-tip inflammatory masses: a consensus statement. Pain Med 3: 313–323PubMedCrossRefGoogle Scholar
  11. 11.
    Hogan Q, Haddox JD, Abram S, Weissman D, Taylor ML, Janjan N (1991) Epidural opiates and local anesthetics for the management of cancer pain. Pain 46: 271–279PubMedCrossRefGoogle Scholar
  12. 12.
    Krames ES (1993) Intrathecal infusional therapies for intractable pain: patient management guidelines. J Pain Sympt Manage 8: 36–46CrossRefGoogle Scholar
  13. 13.
    Lanning RM, Hrushesky WJM (1990) Cost comparison of wearable and implantable drug delivery systems. Proc ASCO 9: 322Google Scholar
  14. 14.
    McMillan MR, Doud T, Nugent W (2003) Catheter-associated masses in patients receiving intrathecal analgesic therapy. Anesth Analg 96: 186–190PubMedCrossRefGoogle Scholar
  15. 15.
    Müller H (2001) Spinale Opioidanalgesie. In: Zenz M, Jurna I (Hrsg) Lehrbuch der Schmerztherapie. Wissenschaftliche Verlagsges., Stuttgart, S 441–456Google Scholar
  16. 16.
    Nitescu P, Appelgren L, Hultman E, Lindner LE, Sjoberg M, Curelaru I (1991) Long-term, open catheterization of the spinal subarachnoid space for continuous infusion of narcotic and bupivacaine in patients with “refractory” cancer pain. Clin J Pain 7: 143–161PubMedGoogle Scholar
  17. 17.
    Patt RB (Hrsg) (1993) Cancer pain. Lippincott, Philadelphia, S 329–341Google Scholar
  18. 18.
    Samuelsson H, Malmberg F, Eriksson M, Hedner T (1995) Outcomes of epidural morphine treatment in cancer pain: nine years of clinical experience. J Pain Sympt Manage 10: 105–112CrossRefGoogle Scholar
  19. 19.
    Sator-Katzenschlager S, Deusch E, Maier P, Spacek A, Kress HG (2001) The long-term antinociceptive effect of intrathecal S(+)-ketamine in a patient with established morphine tolerance. Anesth Analg 93: 1032–1034PubMedCrossRefGoogle Scholar
  20. 20.
    Sjoberg M, Nitescu P, Appelgren L, Curelaru I (1994) Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Anesthesiology 80: 284–297PubMedCrossRefGoogle Scholar
  21. 21.
    Smith DE (1990) Spinal opioids in the home and hospice setting. J Pain Sympt Manage 5: 175–182CrossRefGoogle Scholar
  22. 22.
    Waldmann CS, Eason JR, Rambohul E, Hanson GC (1984) Serum morphine levels. A comparison between continuous subcutaneous infusion and continuous intravenous infusion in postoperative patients. Anaesthesia 39: 768–771PubMedGoogle Scholar
  23. 23.
    Yaksh TL (1996) Intrathecal and epidural opiates: a review. In: Campbell JN (Hrsg) Pain 1996 — an updated review. IASP Press, Seattle, S 381–393Google Scholar
  24. 24.
    Yaksh TL, Hassenbusch S, Burchiel K, Hildebrand KR, Page LM, Coffey RJ (2002) Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. Pain Med 3: 300–312PubMedCrossRefGoogle Scholar
  25. 25.
    Yaksh TL, Horais KA, Tozier NA, Allen JW, Rathbun M, Rossi SS, Sommer C, Meschter C, Richter PJ, Hildebrand KR (2003) Chronically infused intrathecal morphine in dogs. Anesthesiology 99: 174–187PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2006

Authors and Affiliations

  • Hans Georg Kress
    • 1
  1. 1.Univ.-Klinik für Anästhesie und Allgemeine IntensivmedizinWien

Personalised recommendations